Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

April 12, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

September 30, 2025

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

SRF388

SRF388 will be administered by intravenous injection (IV)

DRUG

Atezolizumab

Azezolizumab will be administered by IV

DRUG

Bevacizumab

Bevacizumab will be administered by IV

DRUG

Placebo

Placebo will be administered by IV

Trial Locations (34)

807

Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung City

970

Buddhist Tzu Chi General Hospital - Hualien Tzu Chi Medical Center, Hualien City

3004

The Alfred Hospital, Melbourne

10002

National Taiwan University Hospital, Taipei

10010

Veterans Affairs New York Harbor Healthcare System - Manhattan VA Medical Center, New York

10016

NYU Langone Medical Center - Laura and Isaac Perlmutter Cancer Center (NYU Cancer Institute (NYUCI)), New York

13620

Seoul National University Bundang Hospital, Seongnam

32610

University of Florida Health Science Center - Gainesville, Gainesville

33136

University of Miami, Sylvester Comprehensive Cancer Center, Miami

37203

Sarah Cannon Research Institute - Tennessee Oncology, Nashville

37404

Sarah Cannon Research Institute - Tennessee Oncology, Chattanooga

40206

Louisville VA Medical Center - Robley Rex VA Medical Center, Louisville

40447

China Medical University Hospital, Taichung

48105

Veterans Affairs Ann Arbor Healthcare System, Ann Arbor

48109

University of Michigan Health System (UMHS), Ann Arbor

48202

Henry Ford Hospital, Detroit

50612

Pusan National University Yangsan Hospital, Yangsan

58128

Chonnam National University (CNU) - Chonnam National University Hwasun Hospital (CNUHH), Gwangju

73104

University of Oklahoma Health Sciences Center - Stephenson Cancer Center, Oklahoma City

82445

E-Da Cancer Hospital, Kaohsiung City

85719

University of Arizona Cancer Center - North Campus, Tucson

90033

University of Southern California - Norris Comprehensive Cancer Center, Los Angeles

91010

City of Hope, Duarte

97213

Providence Portland Medical Center, Portland

Unknown

Royal Melbourne Hospital, Melbourne

442-723

The Catholic University of Korea - St. Vincent's Hospital, Suwon

705-718

Daegu Catholic University Medical Center (DCUMC), Daegu

443-721

Ajou University Hospital, Gyeonggi-do

463-712

CHA University - Bundang CHA General Hospital (CHA Bundang Medical Center), Gyeonggi-do

03722

Severance Hospital, Seoul

135-720

Gangnam Severance Hospital - Cancer Hospital, Seoul

136-705

Korea University Medical Center - Korea University Anam Hospital, Seoul

138-736

University of Ulsan College of Medicine - Asan Medical Center (AMC), Seoul

156-707

Seoul National University Hospital (SNUH) - SMG-SNU Boramae Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Coherus Oncology, Inc.

INDUSTRY